Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

Clinical trial NCT00280995 · COMPLETED

Trial details

NCT number: NCT00280995
Sponsor: Kastle Therapeutics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia, Familial

Start date: 2006-01-01
Primary completion: 2007-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.